81 related articles for article (PubMed ID: 21515447)
1. [Inhibitory effect of fluvastatin on lysophosphatidylcholine-induced ventricular arrhythmias in rats].
Li LB; Wang HY; Ma L; Gao CQ
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Apr; 31(4):578-81. PubMed ID: 21515447
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of fluvastatin on lysophosphatidylcholine-induced nonselective cation current in Guinea pig ventricular myocytes.
Li L; Matsuoka I; Suzuki Y; Watanabe Y; Ishibashi T; Yokoyama K; Maruyama Y; Kimura J
Mol Pharmacol; 2002 Sep; 62(3):602-7. PubMed ID: 12181436
[TBL] [Abstract][Full Text] [Related]
3. Lysophosphatidylcholine enhances I(Ks) currents in cardiac myocytes through activation of G protein, PKC and Rho signaling pathways.
Ding WG; Toyoda F; Ueyama H; Matsuura H
J Mol Cell Cardiol; 2011 Jan; 50(1):58-65. PubMed ID: 20950624
[TBL] [Abstract][Full Text] [Related]
4. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
Morikawa-Futamatsu K; Adachi S; Maejima Y; Tamamori-Adachi M; Suzuki J; Kitajima S; Ito H; Isobe M
Life Sci; 2006 Aug; 79(14):1380-90. PubMed ID: 16712874
[TBL] [Abstract][Full Text] [Related]
5. [Regulation of T-type Ca(2+) channel in lysophosphatidylcholine-stimulated cardiomyocytes].
Liu G; Zheng MQ; Wang W; Wang XY; Ma FF; Yu HF; Li XY
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Dec; 43(6):804-8. PubMed ID: 22178824
[TBL] [Abstract][Full Text] [Related]
6. Chronic fluvastatin treatment alters vascular contraction by inhibiting the Rho/Rho-kinase pathway.
Kansui Y; Fujii K; Goto K; Oniki H; Iida M
Clin Exp Pharmacol Physiol; 2006 Aug; 33(8):673-8. PubMed ID: 16895538
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidylcholine metabolism and cardiac arrhythmias.
Giffin M; Arthur G; Choy PC; Man RY
Can J Physiol Pharmacol; 1988 Mar; 66(3):185-9. PubMed ID: 3383014
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidylcholine increases Na+/Ca2+ exchanger expression via RhoB-geranylgeranylation in H9c2 cells.
Maeda S; Sakamoto K; Matsuoka I; Iwamoto T; Kimura J
J Pharmacol Sci; 2009 Apr; 109(4):565-72. PubMed ID: 19352075
[TBL] [Abstract][Full Text] [Related]
9. Lysophosphatidylcholine-induced arrhythmias and its accumulation in the rat perfused heart.
Man RY
Br J Pharmacol; 1988 Feb; 93(2):412-6. PubMed ID: 3359113
[TBL] [Abstract][Full Text] [Related]
10. PKCɛ mediates serine phosphorylation of connexin43 induced by lysophosphatidylcholine in neonatal rat cardiomyocytes.
Liao CK; Cheng HH; Wang SD; Yeih DF; Wang SM
Toxicology; 2013 Dec; 314(1):11-21. PubMed ID: 23973256
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of Na+/Ca2+ exchanger by fluvastatin in rat cardiomyoblast H9c2 cells: involvement of RhoB in Na+/Ca2+ exchanger mRNA stability.
Maeda S; Matsuoka I; Iwamoto T; Kurose H; Kimura J
Mol Pharmacol; 2005 Aug; 68(2):414-20. PubMed ID: 15879517
[TBL] [Abstract][Full Text] [Related]
12. Effect of reduced calcium on lysophosphatidylcholine-induced cardiac arrhythmias.
Man RY; Lederman CL
Pharmacology; 1985; 31(1):11-6. PubMed ID: 4023041
[TBL] [Abstract][Full Text] [Related]
13. Modulation of nonselective cation current by oxidized LDL and lysophosphatidylcholine and its inhibitory contribution to endothelial damage.
Liang GH; Park S; Kim MY; Kim JA; Choi S; Suh SH
Life Sci; 2010 May; 86(19-20):733-9. PubMed ID: 20226792
[TBL] [Abstract][Full Text] [Related]
14. Involvement of peptidyl-prolyl isomerase Pin1 in the inhibitory effect of fluvastatin on endothelin-1-induced cardiomyocyte hypertrophy.
Sakai S; Shimojo N; Kimura T; Tajiri K; Maruyama H; Homma S; Kuga K; Mizutani T; Aonuma K; Miyauchi T
Life Sci; 2014 May; 102(2):98-104. PubMed ID: 24657892
[TBL] [Abstract][Full Text] [Related]
15. Lysophosphatidylcholine-induced myocardial damage is inhibited by pretreatment with poloxamer 188 in isolated rat heart.
Watanabe M; Okada T
Mol Cell Biochem; 2003 Jun; 248(1-2):209-15. PubMed ID: 12870676
[TBL] [Abstract][Full Text] [Related]
16. Lysophosphatidylcholine induces glial cell activation: role of rho kinase.
Sheikh AM; Nagai A; Ryu JK; McLarnon JG; Kim SU; Masuda J
Glia; 2009 Jun; 57(8):898-907. PubMed ID: 19115379
[TBL] [Abstract][Full Text] [Related]
17. Fluvastatin prevents vascular hyperplasia by inhibiting phenotype modulation and proliferation through extracellular signal-regulated kinase 1 and 2 and p38 mitogen-activated protein kinase inactivation in organ-cultured artery.
Sakamoto K; Murata T; Chuma H; Hori M; Ozaki H
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):327-33. PubMed ID: 15591221
[TBL] [Abstract][Full Text] [Related]
18. Fluvastatin ameliorates podocyte injury in proteinuric rats via modulation of excessive Rho signaling.
Shibata S; Nagase M; Fujita T
J Am Soc Nephrol; 2006 Mar; 17(3):754-64. PubMed ID: 16452496
[TBL] [Abstract][Full Text] [Related]
19. Lysophosphatidylcholine modulates cardiac I(Na) via multiple protein kinase pathways.
Watson CL; Gold MR
Circ Res; 1997 Sep; 81(3):387-95. PubMed ID: 9285641
[TBL] [Abstract][Full Text] [Related]
20. Intracellular Ca(2+)- and PKC-dependent upregulation of T-type Ca(2+) channels in LPC-stimulated cardiomyocytes.
Zheng M; Wang Y; Kang L; Shimaoka T; Marni F; Ono K
J Mol Cell Cardiol; 2010 Jan; 48(1):131-9. PubMed ID: 19744490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
